Intuitive Surgical, Inc.

General ticker "ISRG" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $171.1B (TTM average)

Intuitive Surgical, Inc. closely follows the US Stock Market performance with the rate: 78.9%.

Estimated limits based on current volatility of 2.4%: low 468.28$, high 491.53$

Factors to consider:

  • Earnings expected soon, date: 2025-04-17 bmo
  • Company included in S&P500 list
  • US accounted for 43.4% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [436.21$, 609.18$]
  • 2025-12-31 to 2026-12-31 estimated range: [418.01$, 592.11$]

Financial Metrics affecting the ISRG estimates:

  • Negative: Operating cash flow per share per price, % of 1.26 <= 1.81
  • Positive: Non-GAAP EPS, $ of 7.33 > 2.18
  • Negative: negative Industry operating income (median)
  • Negative: Industry earnings per price (median), % of -5.86 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -3.89 <= 2.91
  • Positive: Operating profit margin, % of 28.12 > 18.56

Similar symbols

Short-term ISRG quotes

2025-02-242025-02-252025-02-262025-02-272025-02-282025-03-032025-03-042025-03-052025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-04460480500520540560580600
Price $

Long-term ISRG plot with estimates

250300350400450500550600Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.511.52
ISRGS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $6,222.20MM $7,124.10MM $8,352.10MM
Operating Expenses $4,645.10MM $5,357.30MM $6,003.20MM
Operating Income $1,577.10MM $1,766.80MM $2,348.90MM
Non-Operating Income $29.70MM $192.10MM $324.90MM
R&D Expense $879.00MM $998.80MM $1,145.30MM
Income(Loss) $1,606.80MM $1,958.90MM $2,673.80MM
Taxes $262.40MM $141.60MM $336.30MM
Profit(Loss)* $1,322.30MM $1,798.00MM $2,322.60MM
Stockholders Equity $11,041.90MM $13,307.60MM $16,433.70MM
Inventory $893.20MM $1,220.60MM $1,487.20MM
Assets $12,974.00MM $15,441.50MM $18,743.20MM
Operating Cash Flow $1,490.80MM $1,813.80MM $2,415.00MM
Capital expenditure $532.40MM $1,064.20MM $1,111.20MM
Investing Cash Flow $1,370.80MM $-360.10MM $-3,272.80MM
Financing Cash Flow $-2,572.30MM $-287.60MM $150.90MM
Earnings Per Share** $3.72 $5.12 $6.54

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.